·Î±×ÀÎ ¸¶ÀÌÆäÀÌÁö ÀÌ¿ë¾È³» °í°´¼¾ÅÍ ¼­ºñ½º¾È³»
ä¿ëÁ¤º¸µî·Ï À̷¼­µî·Ï
ä¿ëÁ¤º¸ ÇìµåÇåÆà ÀÎÀçÁ¤º¸ Ä¿¹Â´ÏƼ °í°´¼¾ÅÍ ¼îÇθô
±â¾÷ȸ¿ø¼­ºñ½º°³ÀÎȸ¿ø¼­ºñ½º
Àαâ°Ë»ö¾î : ¿µ¾÷ ¸¶ÄÉÆà ÀÓ»ó ¿¬±¸ Ç°Áú°ü¸® ÀλçÃѹ« »ý»êÁ÷ ¾à»ç ÀÎÇã°¡ °£È£»ç
ȸ¿ø°¡ÀÔ¾ÆÀ̵ð/ºñ¹Ð¹øȣã±â
ä¿ëÁ¤º¸
Àüüä¿ëÁ¤º¸
Áö¿ªº°
Á÷Á¾º°
¿ª¼¼±Çº°
±Þ¿©º°
»ó¼¼°Ë»ö
±Ù¹«Çüź°
ÃßÈÄÇùÀÇ
ÀÎÅÏÁ÷
Á¤±ÔÁ÷
°è¾àÁ÷
º´¿ªÆ¯·Ê
ÇÁ¸®·£¼­
Çзº°
ÃʵîÇб³
ÁßÇб³
°íµîÇб³
´ëÇÐ(2~3³â) ÀçÇÐ
´ëÇÐ(2~3³â) Á¹¾÷
´ëÇÐ(4³â) ÀçÇÐ
´ëÇÐ(4³â) Á¹¾÷
´ëÇпø(¼®»ç) Á¹¾÷
´ëÇпø(¹Ú»ç) Á¹¾÷
°æ·Âº°
½ÅÀÔ
1³âÀÌ»ó~3³â¹Ì¸¸
3³âÀÌ»ó~5³â¹Ì¸¸
5³âÀÌ»ó~10³â¹Ì¸¸
10³âÀÌ»ó
 
 
 
Á÷Á¾
Áö¿ª ¼ºº° ÇзÂ
°æ·Â Å°¿öµå
µî·ÏÀϼø | ¼öÁ¤Àϼø | ¸¶°¨Àϼø | Á¶È¸¼ø | °æ·Â¡è | °æ·Â¡é
  ȸ»ç¸í ä¿ëÁ¤º¸Á¦¸ñ ¸ðÁýÁ÷Á¾ °æ·Â ¸¶°¨ÀÏ ¼öÁ¤ÀÏ
Pharmax Ogilvy Healthworld CRA¸ðÁý (´ë¸® °úÀå±Þ)
¼­¿ï ¼­Ãʱ¸ | ´ëÇÐ(2~3³â) Á¹¾÷
CRA/ÀÓ»óPM/CRM 3³â¡è ä¿ë½Ã 09.29
Pharmax Ogilvy Healthworld CRA ¸ðÁý(´ë¸®°úÀå±Þ)
¼­¿ï ¼­Ãʱ¸ | ´ëÇÐ(2~3³â) Á¹¾÷
CRA/ÀÓ»óPM/CRM 2³â¡è ä¿ë½Ã 09.20
Ä¿¸®¾îHR
¼­¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) ÀçÇÐ
¿¬±¸/¿¬±¸±âȹ 1³â¡è ä¿ë½Ã 12.03
¿òÆ® ÀÓ»ó½ÃÇè CRM (Clinical Research Manager) °æ·ÂÁ÷ ä¿ë
¼­¿ï ±¸·Î±¸ | ´ëÇÐ(4³â) Á¹¾÷
CRA/ÀÓ»óPM/CRM 4³â¡è ä¿ë½Ã 05.19
À¯´Ï¸ÞµåÁ¦¾àÁÖ½Äȸ»ç ÀÓ»óÇмúÆÀ ÀÓ»óÆÄÆ® °æ·ÂÁ÷ ¸ðÁý
¼­¿ï ¼ÛÆı¸ | ´ëÇÐ(4³â) Á¹¾÷
CRA/ÀÓ»óPM/CRM 1³â¡è ä¿ë½Ã 02.16
(ÁÖ)Áö¿¡½º½ºÅÄ´Ùµå CRA, PMä¿ë
¼­¿ï ±¸·Î±¸ | ´ëÇÐ(4³â) Á¹¾÷
CRA/ÀÓ»óPM/CRM 5³â¡è ä¿ë½Ã 02.12
(ÁÖ)½Ã¹ÍÄÚ¸®¾Æ (ÁÖ)½Ã¹ÍÄÚ¸®¾Æ CRA I, II, Sr. °æ·ÂÁ÷ ä¿ë
¼­¿ï °­³²±¸ | ´ëÇÐ(4³â) Á¹¾÷
CRA/ÀÓ»óPM/CRM 2³â¡è ä¿ë½Ã 11.28
½ÃÁö¹ÙÀÌ¿À ½ºÅÙÆ®TFT CRA ä¿ë °Ç
°æ±â ¼º³²½Ã Áß¿ø±¸ | ´ëÇÐ(4³â) Á¹¾÷
CRA/ÀÓ»óPM/CRM 3³â¡è »ó½Ãä¿ë 01.09
PRA Health Sciences CRA, Sr. CRA
¼­¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷
CRA/ÀÓ»óPM/CRM 1³â¡è ä¿ë½Ã 04.18
PRA Health Sciences [PRA Health Sciences] CRA I, II, III, Drug Safety Associ
¼­¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) ÀçÇÐ
CRA/ÀÓ»óPM/CRM 1³â¡è ä¿ë½Ã 06.28
(ÁÖ)¾¾¿£¾Ë¸®¼­Ä¡ ¾¾¿£¾Ë¸®¼­Ä¡ °­³², ºÎ»ê [°æ·Â] CRA ä¿ë
¼­¿ï °­³²±¸, ºÎ»ê ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷
CRA/ÀÓ»óPM/CRM 1³â¡è ä¿ë½Ã 08.06
(ÁÖ)¸ÞµðÇïÇÁ¶óÀÎ ¸ÞµðÇïÇÁ¶óÀÎ Àӻ󿬱¸ CR °æ·Â&½ÅÀÔ Ã¤¿ë
¼­¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷
CRA/ÀÓ»óPM/CRM °æ·Â¹«°ü ä¿ë½Ã 09.22
(ÁÖ)¾¾¿£¾Ë¸®¼­Ä¡ ¹ÙÀÌ¿À, ÀÓ»ó CRO [¾¾¿£¾Ë¸®¼­Ä¡] ºÎ»ê »çºÎ¼Ò CRA ä¿ë
ºÎ»ê ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷
CRA/ÀÓ»óPM/CRM °æ·Â¹«°ü ä¿ë½Ã 07.13
(ÁÖ)Çѱ¹ÀǾ࿬±¸¼Ò ÀÓ»ó¸ð´ÏÅ͸µ¿ä¿ø(CRA) °æ·Â»ç¿ø ¸ðÁý
°æ±â ¼º³²½Ã Áß¿ø±¸ | Çз¹«°ü
CRA/ÀÓ»óPM/CRM 1³â¡è ä¿ë½Ã 03.13
PRA Health Sciences [PRA Health Sciences] CRA I, II, III, Contract Represent
¼­¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷
CRA/ÀÓ»óPM/CRM 1³â¡è ä¿ë½Ã 11.14
1   2   3   4   5   6   7   8   9   10  
°³ÀÎÁ¤º¸Ã³¸®¹æħ | ȸ¿ø¾à°ü | °í°´Áö¿ø¼¾ÅÍ | Á¦ÈÞ ¹× ±¤°í¹®ÀÇ | ´ÙÀÌ·ºÆ®°áÁ¦